Virology Diseases-2024| London, UK

Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Virology Diseases-2024

Welcome Message

Join us in London,UK, on November 20-21, 2024, for the 7th World Congress on Virology and Diseases Control. Themed "Advancing Global Health Through Vaccination," our conference aims to foster collaboration and innovation among experts in virology, infectious diseases, and vaccination to address urgent viral disease challenges.

This conference provides a vital platform for leading minds to advance the global health agenda through pioneering research and inventive strategies. Discussions will focus on vaccine development, equitable access, and effectiveness, aiming to overcome vaccine hesitancy and strengthen pandemic preparedness efforts worldwide.

Join scientists, clinicians, policymakers, and industry leaders in shaping the future of global health at the Virology Diseases 2024. Don't miss this transformative opportunity to drive progress in virology, emerging diseases, and vaccination. Save the date and see you in Uk!

Lead the way in innovation by securing your registration and submitting your abstract to this momentous virology conference, as the official countdown has started!

 

Why to Attend/ Sponsor/ Exhibitor

The 7th World Congress on Virology and Diseases Control is a unique and exciting opportunity, have been designed in an interdisciplinary manner with a multitude of tracks to showcase the new technology, the new products of your company, the service your industry may offer to a broad international audience. It covers a lot of topics and it will be a nice platform to showcase their recent research on Virology Applications.

Business networking is an avenue for vendors to have network and B2B meetings with “Top Scientists and Colleagues” and with an effective low-cost marketing method for developing sales and opportunities and contacts, based on referrals and introductions either face-to-face at meetings and gatherings, or by other contact methods such as Telephone, E mail, Digital and increasingly social and business networking websites.

Your sponsorship/exhibition will give your organization fantastic exposure to around 150 attendees, and offers a unique opportunity to align your brand with this very highly successful, high profile event.

Virology Diseases 2024 will provide a terrific and diverse platform to interact and network with fellow industry colleagues.
 

2024 Highlights:

  • 150 Participation (70 Industry: 30 Academia)

  • 10+ Keynote Speakers

  • 50+ Plenary Speakers

  • 05+ Exhibitors

  • 12 Innovative Educational Sessions

  • 5+ Workshops

Benefits of Attending

  • To foster discussions, share expertise and exchange knowledge and best practices at all levels of the healthcare spectrum

  • To encourage collaboration and enhance interactions at a global level

  • Meet a range of specialists actively practicing in the field

  • Strengthen your profile and position your organization as a key industry figure

  • Develop new partnerships and networks with key decision makers/influencers

  • Open doors for your organization to connect and develop strategic relationships in a neutral and relaxed sales environment

  • Get access to targeted audience

  • Brand Exposure – Promote your company’s message, products and services through a national Conference marketing campaign

  • First hand live demonstrations to delegates

  • To showcase new healthcare technologies and solutions in an intimate setting focused specifically on microbiology.

Targeted Audience

  • Directors, CEO’s of Organizations

  • Business Development Managers

  • Chief Scientific Officers

  • R&D Researchers from Pharma Industries

  • Professors, Associate Professors, Assistant Professors

  • PhD Scholars

  • Association, Association presidents and professionals

  • Noble laureates in Health Care and Medicine

  • Research Institutes and members

  • Manufacturing Companies

  • Training Institutes

Sessions & Tracks

Track-1: Basic Virology

Explore the fundamental principles of virology in this track, where we delve into the intricate world of viruses and their interactions with host organisms. From the molecular mechanisms of viral replication to the structural dynamics of viral genomes, this track offers insights into the essential building blocks of virology.

Join us to unravel the complexities of host-virus interactions, including the role of cellular receptors, immune responses, and viral evasion strategies. Gain a deeper understanding of viral evolution and phylogenetic, exploring how viruses adapt and diversify over time. Learn about viral pathogenesis and the mechanisms underlying disease development, from acute infections to chronic conditions. Whether you're a seasoned researcher or a budding scientist, this track provides a solid foundation in basic virology principles that are essential for advancing our knowledge and combating viral diseases.

  • Molecular virology

  • Viral replication mechanisms

  • Viral genome structure and function

  • Host-virus interactions

  • Viral evolution and phylogenetics

Track-2: Clinical Virology

Dive into the dynamic field of clinical virology in this track, where we explore the intersection of virology with medical practice and patient care. From diagnostic techniques to treatment strategies, this track covers a wide range of topics essential for understanding and managing viral infections. Learn about the latest advances in diagnostic virology, including molecular and serological methods for detecting viral pathogens with precision and accuracy. Explore antiviral therapies and treatment modalities, from traditional drugs to novel biologics and immunotherapies, aimed at combating viral diseases. Gain insights into the epidemiology and surveillance of viral outbreaks, including strategies for outbreak investigation, contact tracing, and containment.

Join us to discover how clinical virology plays a pivotal role in public health preparedness and response, from seasonal influenza to emerging infectious diseases like COVID-19. Whether you're a clinician, laboratory scientist, or public health professional, this track provides valuable insights and practical knowledge for managing viral infections in clinical settings.

  • Diagnosis of viral infections

  • Antiviral therapies

  • Vaccine development and strategies

  • Epidemiology of viral diseases

Track-3: Viral Pathogenesis

Unravel the mysteries of viral pathogenesis in this enlightening track, where we delve into the mechanisms by which viruses cause disease in their hosts. From initial infection to the onset of clinical symptoms, this track explores the intricate interplay between viral pathogens and host cells. Discover how viruses breach host defences, evade immune surveillance, and hijack cellular machinery to establish infection and propagate within the body. Explore the diverse strategies employed by viruses to manipulate host signalling pathways, disrupt cellular functions, and evade antiviral defences. Gain insights into the immunological responses triggered by viral infections, from innate immune activation to adaptive immune memory. Learn about the factors influencing disease severity, including viral virulence factors, host genetics, and environmental factors.

Join us to unravel the complexities of viral pathogenesis and pave the way for the development of novel therapeutics and vaccines targeting viral diseases. Whether you're a basic scientist, clinician, or public health expert, this track offers valuable insights into the mechanisms underlying viral infections and their impact on human health.

  • Mechanisms of viral pathogenesis

  • Host immune responses to viral infections

  • Viral oncogenesis

  • Viral immunopathology

Track-4: Viral Genomics and Bioinformatics

Embark on a journey into the realm of viral genomics and bioinformatics in this track, where we explore the genetic diversity and computational intricacies of viral pathogens. Dive deep into the genomes of viruses, unravelling their genetic makeup, and deciphering the molecular codes that govern viral replication, evolution, and pathogenesis. Explore cutting-edge genomic sequencing technologies and bioinformatics tools, revolutionizing our understanding of viral diversity, evolution, and transmission dynamics.

Discover how computational analyses and predictive modelling techniques are reshaping our approach to viral research, diagnosis, and therapeutic development. From viral metagenomics to phylogenetic reconstruction, this track offers insights into the power of genomics and bioinformatics in unravelling the mysteries of viral diseases. Join us to harness the potential of genomic data and computational algorithms in the fight against emerging viral threats and infectious diseases. Whether you're a molecular biologist, bioinformatician, or computational scientist, this track provides a platform to explore the intersection of genomics, bioinformatics, and virology, shaping the future of viral research and public health.

  • Genomic sequencing of viruses

  • Computational virology

  • Viral metagenomics

  • Viral bioinformatics tools and databases

Track-5: Vaccines and Immunization Strategies

Vaccines and immunization strategies are essential tools in preventing infectious diseases by stimulating the immune system to produce protective immunity against pathogens. Vaccines contain weakened or inactivated forms of the pathogen or specific antigens that trigger an immune response without causing illness.

Track-6: Viral Ecology and Evolution

Join us on a captivating journey into the realms of viral ecology and evolution in this illuminating track. Here, we delve into the intricate dance between viruses, their hosts, and the environment, unravelling the mysteries of viral diversity, distribution, and transmission across various ecosystems. Explore the driving forces behind viral adaptation and evolution, from genetic drift to the selective pressures imposed by host immunity and environmental changes. Investigate the fascinating phenomena of cross-species transmission and zoonotic spill over events, shedding light on the origins of emerging viral diseases. Delve into the ways in which human activities, such as urbanization and climate change, impact viral ecology and facilitate the emergence of novel pathogens.

Join us as we unravel the complex tapestry of interactions between viruses, hosts, and ecosystems, gaining insights into the ecological and evolutionary dynamics shaping infectious disease emergence and transmission. Whether you're an ecologist, evolutionary biologist, or public health researcher, this track offers a multidisciplinary exploration of viral ecology and evolution, advancing our understanding of viral dynamics in a rapidly changing world.

  • Environmental virology

  • Viral diversity and ecology

  • Evolutionary dynamics of viruses

  • Zoonotic transmission and spillover events

Track-7: Viral Vaccines and Immunology

Embark on a transformative journey into the realm of viral vaccines and immunology in this pivotal track. Explore the forefront of vaccine development and immunological research, uncovering innovative strategies to combat viral pathogens and bolster immune defences. Delve into the intricacies of viral antigenicity, epitope mapping, and immune recognition, illuminating the molecular basis of protective immunity against viral infections. Discover the latest advancements in vaccine platforms, from traditional attenuated and inactivated vaccines to cutting-edge mRNA and viral vector-based approaches, revolutionizing vaccine design and delivery. Investigate the principles of immune memory and vaccination strategies, including prime-boost regimens, adjuvants, and novel antigen delivery systems, aimed at enhancing vaccine efficacy and durability.

Join us as we navigate the complexities of vaccine development, clinical trials, and regulatory pathways, accelerating the translation of promising candidates from bench to bedside. Whether you're a vaccinology’s, immunologist, clinician, or public health advocate, this track offers a comprehensive exploration of viral vaccines and immunology, paving the way for a future where infectious diseases are conquered through the power of vaccination and immune protection.

  • Vaccine design and development

  • Immunization strategies

  • Vaccine efficacy and safety

  • Immunological responses to viral vaccines

Track-8: Public Health and Epidemiology

Enter the forefront of public health and epidemiology in this pivotal track. Explore the evolving landscape of disease surveillance, outbreak investigation, and community-based interventions designed to protect public health. Delve into the core principles of epidemiological research, unravelling patterns and determinants of disease transmission, spread, and impact within populations. Investigate the pivotal role of public health systems and readiness in mitigating the burden of infectious diseases, from routine immunizations to strategies for pandemic preparedness. Engage with the multidisciplinary aspects of public health, forging connections between epidemiology, biostatistics, environmental health, and social determinants of health.

Join us to address emerging challenges in global health security, including antimicrobial resistance, vaccine hesitancy, and the nexus between infectious and non-communicable diseases. Whether you're a public health professional, epidemiologist, policymaker, or community advocate, this track provides a forum to exchange ideas, share best practices, and collaborate on solutions to advance health equity and resilience worldwide. Together, let's shape the future of public health and epidemiology, ensuring the well-being of communities across the globe.

  • Surveillance of viral diseases

  • Outbreak investigation and control

  • Pandemic preparedness

  • Public health interventions for viral diseases

Track-9: Coronavirus Disease (COVID-19)

COVID-19 is a highly contagious respiratory illness caused by the novel coronavirus SARS-CoV-2. It was first identified in Wuhan, China, in late 2019 and has since evolved into a global pandemic. COVID-19 primarily spreads through respiratory droplets and contact with contaminated surfaces.

Track-10: Therapeutics and Antiviral Agents

Embark on an enlightening journey into the realm of therapeutics and antiviral agents in this pivotal track. Explore the forefront of drug discovery, development, and clinical application, unveiling innovative strategies to combat viral infections and alleviate disease burden. Delve into the molecular mechanisms of viral replication and pathogenesis, uncovering vulnerabilities and targets for therapeutic intervention. Investigate the latest advancements in antiviral drug design, from small molecule inhibitors to biologics and gene-based therapies, revolutionizing treatment options for viral diseases.

Explore synergistic approaches such as combination therapy and immunomodulation, enhancing efficacy and reducing the risk of resistance. Join us as we navigate the complexities of drug development pipelines, clinical trials, and regulatory pathways, accelerating the translation of promising candidates into safe and effective therapies. Whether you're a pharmaceutical researcher, clinician, or healthcare provider, this track offers a comprehensive exploration of therapeutics and antiviral agents, paving the way for improved patient outcomes and global health security.

  • Development of antiviral drugs

  • Mechanisms of antiviral action

  • Resistance to antiviral therapy

  • Combination therapies and drug cocktails

Track-11: Viral Diagnostics and Laboratory Techniques

Immerse yourself in the realm of viral diagnostics and laboratory techniques with this essential track. Discover the latest advancements in diagnostic technologies and laboratory methodologies, offering new avenues for swift and precise identification of viral pathogens. Uncover the intricacies of molecular diagnostics, immunoassays, and point-of-care testing, showcasing a diverse toolkit for viral detection and characterization. Explore the pivotal role of high-throughput sequencing and bioinformatics in viral surveillance and outbreak analysis, providing crucial insights into viral diversity, evolution, and transmission dynamics. Delve into emerging diagnostic techniques like digital PCR, nanopore sequencing, and mass spectrometry, pushing the boundaries of sensitivity, specificity, and throughput in viral testing.

Join us for discussions on quality assurance, standardization, and validation practices in viral diagnostics, ensuring the accuracy and consistency of laboratory findings. Whether you're a clinical microbiologist, laboratory technologist, or infectious disease specialist, this track offers a comprehensive exploration of viral diagnostics and laboratory techniques, empowering healthcare professionals to effectively combat viral infections and safeguard public health.

  • Diagnostic methods for viral infections

  • Point-of-care testing

  • High-throughput sequencing technologies

  • Novel diagnostic approaches

Track-12: One Health Approaches to Virology

Embark on an interdisciplinary journey into the realm of One Health approaches to virology in this pivotal track. Explore the interconnectedness of human, animal, and environmental health, unveiling the complex dynamics of viral transmission, emergence, and spill over between species. Delve into the principles of zoonotic diseases and cross-species transmission, shedding light on the origins of viral pathogens and their potential to cause global pandemics. Investigate the role of wildlife reservoirs, domestic animals, and agricultural practices in shaping viral ecology and evolution, highlighting the need for collaborative efforts to mitigate zoonotic risks. Explore the interface between human health, animal health, and environmental conservation, fostering synergistic strategies for disease surveillance, prevention, and control.

Join us as we discuss the challenges and opportunities of One Health approaches in addressing emerging viral threats, from Ebola and Zika to COVID-19. Whether you're a veterinarian, epidemiologist, environmental scientist, or public health practitioner, this track offers a platform to explore the interconnected nature of health and the vital role of collaboration in protecting the well-being of people, animals, and ecosystems worldwide.

  • Interactions between human, animal, and environmental health

  • Cross-species transmission of viruses

  • Surveillance at the human-animal-environment interface

  • Collaborative efforts to address zoonotic viral threats

Track-13: Pediatric Infectious Diseases

Pediatric infectious diseases encompass a wide range of illnesses affecting infants, children, and adolescents, often with unique clinical manifestations and management considerations. Common pediatric infectious diseases include respiratory tract infections, gastrointestinal illnesses, vaccine-preventable diseases, and childhood infections such as chickenpox and hand-foot-and-mouth disease.

Track-14: Veterinary Diseases

Veterinary diseases are illnesses that affect animals, encompassing a wide range of conditions that can impact livestock, pets, wildlife, and aquatic species. These diseases may be caused by bacteria, viruses, parasites, fungi, or other pathogens and can have significant economic, public health, and ecological consequences. Veterinary medicine plays a crucial role in the prevention, diagnosis, and treatment of animal diseases, employing various strategies such as vaccination, biosecurity measures, and antimicrobial therapy to control disease spread and promote animal welfare.

Track-15: Bacterial Infectious Diseases

Bacterial infectious diseases are caused by pathogenic bacteria capable of invading and colonizing host tissues, leading to a range of clinical manifestations. Common bacterial infections include pneumonia, urinary tract infections, skin and soft tissue infections, and gastrointestinal illnesses.

Market Analysis

"Global Virology Testing Market: Industry Trends and 2029 Forecast"

The global virology testing market encompasses a wide array of procedures, diagnosis tests, methods, and applications. These include the Cell Culture Method, Specific Antibodies Detection, Antigen Detection, Virus Nucleic Acid Detection, Gene Sequencing, and Hemagglutination Assays as procedures. Diagnosis tests cover Hepatitis B, Hepatitis C, HIV, Human Papillomavirus (HPV), and other tests. Methods employed consist of Immunoprophylaxis, Active Prophylaxis (Vaccines), Passive Prophylaxis, Antiviral Chemotherapy, and Interferon's (Cytokines). Read more...

Participant Options & Benefits

Virology Diseases-2024 offers a range of participant options and benefits designed to enhance your conference experience and maximize your professional development. Participants can choose from the following options:

1. Delegate Registration:

  • Access to all scientific sessions, keynote lectures, and workshops.

  • Networking opportunities with fellow professionals and experts in the field.

  • Conference materials, including abstract books and program schedules.

2. Presenter Registration:

  • Opportunity to present your research findings through oral or poster presentations.

  • Feedback from peers and experts in the field.

  • Publication opportunities in conference proceedings or affiliated journals.

3. Student Registration:

  • Special rates for students currently enrolled in academic programs.

  • Access to educational sessions and networking opportunities.

  • Opportunity to showcase research projects through poster presentations.

4. Industry Registration:

  • Exhibition space to showcase products, services, and innovations.

  • Networking opportunities with key opinion leaders and professionals.

  • Brand visibility among a targeted audience of healthcare professionals.

5. Virtual Attendance:

  • Access to live-streamed sessions and on-demand recordings.

  • Participation in interactive sessions and virtual networking events.

  • Flexibility to attend sessions from anywhere in the world.

Benefits for Participants:

  • Stay updated on the latest advancements and research findings in nephrology and urology.

  • Expand your professional network and connect with peers and experts in the field.

  • Enhance your knowledge and skills through interactive workshops and educational sessions.

  • Explore career opportunities and collaborations in nephrology and urology.

  • Earn continuing education credits and enhance your professional credentials.

Join Us at Virology Diseases-2024  whether you are a researcher, clinician, student, or industry professional,Virology Diseases-2024 offers a valuable opportunity to learn, network, and collaborate with experts in the field. Register today and be a part of this exciting event in Amsterdam, Netherlands!

To Collaborate Scientific Professionals around the World

Conference Date November 20-21, 2024

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Virology: Current Research Virology & Mycology Journal of Virology & Antiviral Research

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Keytopics

  • Antimicrobial Stewardship
  • Antiviral Drug Development
  • Antiviral Drug Resistance
  • Antiviral Immunity
  • Bacteriophages
  • Behavioral And Social Determinants Of Health
  • Biosecurity And Biosafety
  • Community Engagement And Public Education
  • Contact Tracing And Case Investigation
  • Emerging And Re-emerging Viruses
  • Emerging Infectious Diseases
  • Enveloped Vs. Non-enveloped Viruses
  • Environmental Monitoring And Control
  • Epidemiology And Surveillance
  • Ethical Issues In Infectious Disease Control
  • Field Epidemiology Training Programs
  • Global Health Organizations And Frameworks
  • Global Health Security
  • Health Communication And Risk Perception
  • Health Informatics And Data Management
  • Health Policy And Governance
  • Health Systems Strengthening
  • Host-Virus Interactions
  • Immune Response To Viral Infections
  • Infection Control In Healthcare Settings
  • Infection Prevention And Control
  • Laboratory Surveillance And Diagnostics
  • Legal And Regulatory Aspects Of Disease Control
  • Modeling And Predictive Analytics In Disease Control
  • One Health Approach
  • Outbreak Investigation And Response
  • Pandemic Preparedness And Response
  • Pathogenesis Of Viral Infections
  • Persistent And Latent Viral Infections
  • Public Health Interventions
  • Quarantine And Isolation Procedures
  • Reverse Genetics In Virology
  • RNA And DNA Viruses
  • Surveillance Of Antiviral Drug Resistance
  • Vaccine Policy And Implementation
  • Vaccines And Immunization
  • Vector Control And Zoonotic Diseases
  • Viral Diagnostics And Detection Methods
  • Viral Entry Mechanisms
  • Viral Epidemiology
  • Viral Evasion Mechanisms
  • Viral Exit Mechanisms
  • Viral Genetics And Mutation
  • Viral Inhibition And Restriction Factors
  • Viral Load And Quantification
  • Viral Oncogenesis
  • Viral Protein Functions And Interactions
  • Viral Replication Cycles
  • Viral Reservoirs And Transmission
  • Viral Tropism
  • Viral Vectors In Gene Therapy
  • Virus Evolution And Quasispecies
  • Virus Structure And Classification
  • Virus-Induced Immunopathology
  • Zoonotic Viruses